Výsledky vyhledávání - "Ayman Al-Shurbaji"

Akademický článek

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure

Autor: Jean‐Claude Tardif, Jean Rouleau, Glenn M. Chertow, Ayman Al‐Shurbaji, Vera Lisovskaja, Stephanie Gustavson, Yanli Zhao, Nadia Bouabdallaoui, Akshay S. Desai, Alexander Chernyavskiy, Maria Evsina, Béla Merkely, John J.V. McMurray, Marc A. Pfeffer

Publikováno v: ESC Heart Failure, Vol 10, Iss 2, Pp 1066-1076 (2023)

Abstract Aims Several patients with heart failure and reduced ejection fraction (HFrEF) do not receive renin–angiotensin–aldosterone system (RAAS) inhibitors at the recommended dose or at all, frequently due to actual or feared hyperkalaemia. Sod

Externí odkaz: https://doaj.org/article/3f9decbc19424144b1f6cdc8f26cf6c0

Zobrazit plný text záznamu

Akademický článek

Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study

Autor: Michel Jadoul, Steven Fishbane, Laura Dember, CP Kovesdy, Ayman Al-Shurbaji, Vera Lisovskaja, Priya Sekar, Brian Katona, Nicolas Guzman, Charles Herzog

Publikováno v: BMJ Open, Vol 13, Iss 5 (2023)

Introduction Patients with kidney failure receiving chronic haemodialysis have elevated risk of arrhythmias potentially increasing the likelihood of sudden cardiac death, stroke and hospitalisation. The DIALIZE study (NCT03303521) demonstrated that s

Externí odkaz: https://doaj.org/article/88fbd23c4438451989c68202499abdea

Zobrazit plný text záznamu

Akademický článek

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

Autor: Steven Fishbane, Martin Ford, Masafumi Fukagawa, Kieran McCafferty, Anjay Rastogi, Bruce Spinowitz, Konstantin Staroselskiy, Konstantin Vishnevskiy, Vera Lisovskaja, Ayman Al-Shurbaji, Nicolas Guzman, Sunil Bhandari

Publikováno v: BMC Nephrology, Vol 23, Iss 1, Pp 1-8 (2022)

Abstract Background Sodium zirconium cyclosilicate (SZC) is an effective and well-tolerated treatment for hyperkalemia in maintenance hemodialysis patients. In post-hoc analyses of the phase 3b DIALIZE study, we examined the spectrum of potassium res

Externí odkaz: https://doaj.org/article/34d28eb0545844c79c1ba2ef8a4c4182

Zobrazit plný text záznamu

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure

Publikováno v: ESC Heart Failure. 10:1066-1076

Several patients with heart failure and reduced ejection fraction (HFrEF) do not receive renin-angiotensin-aldosterone system (RAAS) inhibitors at the recommended dose or at all, frequently due to actual or feared hyperkalaemia. Sodium zirconium cycl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fae4bb24354ed9812e3c9872e393d9
https://doi.org/10.1002/ehf2.14268

Zobrazit plný text záznamu

A Phase 1, open-label, crossover study evaluating the effect of a single dose of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin

Autor: Mats Någård, Nurul Choudhury, Ayman Al-Shurbaji, Vera Lisovskaja, Neil Mackillop

Publikováno v: Clinical Kidney Journal. 16:151-158

Background Sodium zirconium cyclosilicate (SZC) is an oral, highly selective potassium binder approved for the treatment of hyperkalaemia in adults. SZC may change the absorption of co-administered drugs that exhibit pH-dependent bioavailability. Thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a5eff4d984f58f19aa1eed13ab674d2
https://doi.org/10.1093/ckj/sfac205

Zobrazit plný text záznamu

Autor: Steven Fishbane, Michel Jadoul, Laura Dember, CP Kovesdy, Ayman Al-Shurbaji, Vera Lisovskaja, Priya Sekar, Brian Katona, Nicolas Guzman, Charles Herzog

Publikováno v: BMJ open, Vol. 13, no.5, p. e071309 (2023)

IntroductionPatients with kidney failure receiving chronic haemodialysis have elevated risk of arrhythmias potentially increasing the likelihood of sudden cardiac death, stroke and hospitalisation. The DIALIZE study (NCT03303521) demonstrated that so

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05101376db7aaf645a7804cd8011a9d4
https://hdl.handle.net/2078.1/275138

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání